Aquamarine Financial (Cayman) Ltd 13F: Quarter-over-Quarter Portfolio Changes
Aquamarine Financial (Cayman) Ltd reported a disclosed portfolio value of approximately $1.8 billion in its latest SEC Form 13F-HR filing for Q2 2026, up 32.6% quarter on quarter. Over the quarter, the fund initiated 1 new position, bought more shares in 9 holdings, and exited 1 position.
Aquamarine Financial (Cayman) Ltd's top buy was Nu Hldgs LTD (NU) . The fund bought 797.8% more shares, lifting the position's portfolio weight by 5.6 percentage points. Its top sell was Proshares Tr II (SCOUSD) . The fund exited the position completely after it had accounted for 2.1% of the previous portfolio.
New PositionsQ2 2026
Securities disclosed for the first time in Q2 2026 that were not present in the prior 13F-HR filing.
| Company | Ticker | Initial Portfolio Weight | History |
|---|---|---|---|
| PAGAYA TECHNOLOGIES LTD | PGY | 1.8% | History → |
Top BuysQ2 2026
The fund's top buys among existing positions in Q2 2026. Ranked by portfolio-weight impact, with the percentage of additional shares shown separately.
| Company | Ticker | Portfolio Weight Change | More Shares | History |
|---|---|---|---|---|
| NU HLDGS LTD | NU | +5.6% | +797.8% | History → |
| BANCO MACRO SA | BMA | +1.3% | +58.2% | History → |
| GRUPO FINANCIERO GALICIA S.A | GGAL | +1.6% | +48.9% | History → |
| YPF SOCIEDAD ANONIMA | YPF | +0.7% | +37.9% | History → |
| BANCO BBVA ARGENTINA S A | BBAR | +0.4% | +37.7% | History → |
| BANCO BRADESCO S A | BBD | +-7.3% | +19.2% | History → |
| ORAMED PHARMACEUTICALS INC | ORMP | +0.1% | +18.9% | History → |
| INNOVIZ TECHNOLOGIES LTD | INVZ | +0.0% | +12.6% | Holders → |
| BANCO SANTANDER BRASIL S A | BSBR | +-1.3% | +5.9% | History → |
Full ExitsQ2 2026
Positions present in the prior 13F-HR filing that no longer appear in Q2 2026.
| Company | Ticker | Last-Reported Portfolio Weight |
|---|---|---|
| PROSHARES TR II | SCOUSD | 2.1% |
Net Portfolio Value ChangeQ2 2026
- $1.4BPrior quarter
- $1.8BCurrent quarter
- +$0.4BNet delta
- +32.6%% change
Methodology & FAQ
How Aquamarine Financial (Cayman) Ltd Quarterly Changes Are Computed
All deltas are sourced from sequential SEC Form 13F-HR filings for Aquamarine Financial (Cayman) Ltd: each row joins the most recent filing against the immediately preceding quarterly filing for the same fund. Share-count changes reflect reported trading activity, while portfolio weights can also move because of market price changes. Portfolio weights are normalized to exclude listed options for comparability. A complete description, including how confidential treatment filings are handled, is documented in the Methodology.
What stocks did Aquamarine Financial (Cayman) Ltd buy in Q2 2026?
In Q2 2026, Aquamarine Financial (Cayman) Ltd initiated 1 new position (PAGAYA TECHNOLOGIES LTD (PGY)); bought more shares of NU HLDGS LTD (NU), BANCO MACRO SA (BMA), GRUPO FINANCIERO GALICIA S.A (GGAL), YPF SOCIEDAD ANONIMA (YPF), BANCO BBVA ARGENTINA S A (BBAR) (the largest 5 of 9 adds).
What stocks did Aquamarine Financial (Cayman) Ltd sell in Q2 2026?
In Q2 2026, Aquamarine Financial (Cayman) Ltd fully sold 1 position (PROSHARES TR II (SCOUSD)).
Which positions did Aquamarine Financial (Cayman) Ltd initiate in Q2 2026?
Aquamarine Financial (Cayman) Ltd established 1 new position in Q2 2026: PAGAYA TECHNOLOGIES LTD (PGY, 1.8%).
Which existing positions saw the largest allocation increases for Aquamarine Financial (Cayman) Ltd in Q2 2026?
Of 9 existing positions with share-count increases in Q2 2026, the largest were: NU HLDGS LTD (NU, +5.6% weight, +797.8% shares), BANCO MACRO SA (BMA, +1.3% weight, +58.2% shares), GRUPO FINANCIERO GALICIA S.A (GGAL, +1.6% weight, +48.9% shares), YPF SOCIEDAD ANONIMA (YPF, +0.7% weight, +37.9% shares), BANCO BBVA ARGENTINA S A (BBAR, +0.4% weight, +37.7% shares), BANCO BRADESCO S A (BBD, +-7.3% weight, +19.2% shares), ORAMED PHARMACEUTICALS INC (ORMP, +0.1% weight, +18.9% shares), INNOVIZ TECHNOLOGIES LTD (INVZ, +0.0% weight, +12.6% shares), BANCO SANTANDER BRASIL S A (BSBR, +-1.3% weight, +5.9% shares).
Which positions did Aquamarine Financial (Cayman) Ltd fully exit in Q2 2026?
Aquamarine Financial (Cayman) Ltd fully exited 1 position in Q2 2026: PROSHARES TR II (SCOUSD, last-reported weight 2.1%).
Which existing positions saw the largest allocation reductions for Aquamarine Financial (Cayman) Ltd in Q2 2026?
Aquamarine Financial (Cayman) Ltd reported no material allocation reductions in existing positions in Q2 2026.
Do quarter-over-quarter 13F allocation changes constitute explicit trading signals?
No. Quarter-over-quarter changes reflect a combination of active trading and market price movement. A weight increase can result from price appreciation alone, without the manager adding shares. Share-count delta is the cleaner indicator of explicit trading activity. All deltas on this page are sourced from sequential SEC Form 13F-HR filings.